These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36154843)

  • 1. Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists.
    De Luca MA; Tocco G; Mostallino R; Laus A; Caria F; Musa A; Pintori N; Ucha M; Poza C; Ambrosio E; Di Chiara G; Castelli MP
    Neuropharmacology; 2022 Dec; 221():109263. PubMed ID: 36154843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkoxy chain length governs the potency of 2-benzylbenzimidazole 'nitazene' opioids associated with human overdose.
    Glatfelter GC; Vandeputte MM; Chen L; Walther D; Tsai MM; Shi L; Stove CP; Baumann MH
    Psychopharmacology (Berl); 2023 Dec; 240(12):2573-2584. PubMed ID: 37658878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide.
    Vandeputte MM; Tsai MM; Chen L; Glatfelter GC; Walther D; Stove CP; Shi L; Baumann MH
    Drug Alcohol Depend; 2023 Aug; 249():109939. PubMed ID: 37276825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of morphine analgesic effect with induction of mu-opioid receptor endocytosis in rats.
    Hashimoto T; Saito Y; Yamada K; Hara N; Kirihara Y; Tsuchiya M
    Anesthesiology; 2006 Sep; 105(3):574-80. PubMed ID: 16931992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
    Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
    J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid.
    Vandeputte MM; Krotulski AJ; Walther D; Glatfelter GC; Papsun D; Walton SE; Logan BK; Baumann MH; Stove CP
    Arch Toxicol; 2022 Jun; 96(6):1845-1863. PubMed ID: 35477798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel µ-opioid receptor ligand with high in vitro and in vivo agonist efficacy.
    Lacko E; Varadi A; Rapavi R; Zador F; Riba P; Benyhe S; Borsodi A; Hosztafi S; Timar J; Noszal B; Furst S; Al-Khrasani M
    Curr Med Chem; 2012; 19(27):4699-707. PubMed ID: 22934777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of recent non-fentanyl synthetic opioids via three different in vitro µ-opioid receptor activation assays.
    Vandeputte MM; Persson M; Walther D; Vikingsson S; Kronstrand R; Baumann MH; Gréen H; Stove CP
    Arch Toxicol; 2022 Mar; 96(3):877-897. PubMed ID: 35072756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling.
    Tsai MM; Chen L; Baumann MH; Canals M; Javitch JA; Lane JR; Shi L
    ACS Chem Neurosci; 2024 Feb; 15(4):854-867. PubMed ID: 38345920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of μ-opioid receptor modulation on the hippocampal network activity of sharp wave and ripples.
    Giannopoulos P; Papatheodoropoulos C
    Br J Pharmacol; 2013 Mar; 168(5):1146-64. PubMed ID: 23043226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic Characterization of Substituted Nitazenes at
    Kozell LB; Eshleman AJ; Wolfrum KM; Swanson TL; Bloom SH; Benware S; Schmachtenberg JL; Schutzer KA; Schutzer WE; Janowsky A; Abbas AI
    J Pharmacol Exp Ther; 2024 Apr; 389(2):219-228. PubMed ID: 38453524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
    Cinar R; Szücs M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function.
    Brasel CM; Sawyer GW; Stevens CW
    Eur J Pharmacol; 2008 Dec; 599(1-3):36-43. PubMed ID: 18930720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy.
    Hull LC; Llorente J; Gabra BH; Smith FL; Kelly E; Bailey C; Henderson G; Dewey WL
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1127-35. PubMed ID: 20008489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
    Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
    Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic tolerance of opioid agonists in mutant mu-opioid receptors expressed in sensory neurons following intrathecal plasmid gene delivery.
    Li G; Ma F; Gu Y; Huang LY
    Mol Pain; 2013 Dec; 9():63. PubMed ID: 24304623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.
    Civciristov S; Huang C; Liu B; Marquez EA; Gondin AB; Schittenhelm RB; Ellisdon AM; Canals M; Halls ML
    J Biol Chem; 2019 Nov; 294(44):16198-16213. PubMed ID: 31515267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.